Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Mar 1;20(3):281-284.
doi: 10.1093/ijnp/pyw092.

Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II

Affiliations
Comment

Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II

Ross J Baldessarini et al. Int J Neuropsychopharmacol. .
No abstract available

PubMed Disclaimer

Comment on

Similar articles

Cited by

References

    1. Baldessarini RJ, Lau KL, Sim J, Sum MY, Sim K. (2016) Suicidal risks in reports of long-term treatment trials for major depressive disorder. Int J Neuropsychopharmacol 19:107–108. - PMC - PubMed
    1. Baldessarini RJ, Lau KL, Sim J, Sum MY, Sim K. (2015) Duration of initial antidepressant treatment and subsequent relapse of major depression. J Clin Psychopharmacol 35:76–77. - PubMed
    1. Baldessarini RJ, Tondo L, Ghiani C, Lepri B. (2010) Discontinuation rate vs. recurrence risk following long-term antidepressant treatment in major depressive disorder patients. Am J Psychiatry 167:934–941. - PubMed
    1. Boulenger JP, Loft H, Florea I. (2012) Randomized clinical study of Lu-AA21004 in the prevention of relapse in patients with major depressive disorder. J Psychopharmacol 26:1408–1416. - PubMed
    1. Dardennes R, Al Anbar N, Divac C, Cohen J.(In press) Suicidal risks in report of reports of long-term treatment trials for major depressive disorder. Int J Neuropsychopharmacol. - PMC - PubMed

Substances